Spending money for a launch that won’t happen

The WSJ writes about the sad story of Myriad Genetics, who paid $200,000 for a huge coming out party at a conference for their Alzheimer’s drug.

Trouble is, the drug didn’t work, so they’re left with an empty, fancy booth.

Tragically comical.